These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 20699480)
1. Disease-specific, neurosphere-derived cells as models for brain disorders. Matigian N; Abrahamsen G; Sutharsan R; Cook AL; Vitale AM; Nouwens A; Bellette B; An J; Anderson M; Beckhouse AG; Bennebroek M; Cecil R; Chalk AM; Cochrane J; Fan Y; Féron F; McCurdy R; McGrath JJ; Murrell W; Perry C; Raju J; Ravishankar S; Silburn PA; Sutherland GT; Mahler S; Mellick GD; Wood SA; Sue CM; Wells CA; Mackay-Sim A Dis Model Mech; 2010; 3(11-12):785-98. PubMed ID: 20699480 [TBL] [Abstract][Full Text] [Related]
2. Concise review: Patient-derived olfactory stem cells: new models for brain diseases. Mackay-Sim A Stem Cells; 2012 Nov; 30(11):2361-5. PubMed ID: 22961669 [TBL] [Abstract][Full Text] [Related]
3. Expression profile of an operationally-defined neural stem cell clone. Parker MA; Anderson JK; Corliss DA; Abraria VE; Sidman RL; Park KI; Teng YD; Cotanche DA; Snyder EY Exp Neurol; 2005 Aug; 194(2):320-32. PubMed ID: 15992799 [TBL] [Abstract][Full Text] [Related]
4. Altered cell cycle dynamics in schizophrenia. Fan Y; Abrahamsen G; McGrath JJ; Mackay-Sim A Biol Psychiatry; 2012 Jan; 71(2):129-35. PubMed ID: 22074612 [TBL] [Abstract][Full Text] [Related]
5. Olfactory stem cells can be induced to express chondrogenic phenotype in a rat intervertebral disc injury model. Murrell W; Sanford E; Anderberg L; Cavanagh B; Mackay-Sim A Spine J; 2009 Jul; 9(7):585-94. PubMed ID: 19345615 [TBL] [Abstract][Full Text] [Related]
6. Stem cell models for biomarker discovery in brain disease. Mackay-Sim A; Mellick G; Wood S Int Rev Neurobiol; 2011; 101():239-57. PubMed ID: 22050854 [TBL] [Abstract][Full Text] [Related]
7. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease. Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154 [TBL] [Abstract][Full Text] [Related]
8. Clonal analysis of adult human olfactory neurosphere forming cells. Othman M; Lu C; Klueber K; Winstead W; Roisen F Biotech Histochem; 2005; 80(5-6):189-200. PubMed ID: 16720519 [TBL] [Abstract][Full Text] [Related]
9. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice. Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872 [TBL] [Abstract][Full Text] [Related]
10. Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia. Wang L; Lockstone HE; Guest PC; Levin Y; Palotás A; Pietsch S; Schwarz E; Rahmoune H; Harris LW; Ma D; Bahn S J Proteome Res; 2010 Jan; 9(1):521-7. PubMed ID: 19916557 [TBL] [Abstract][Full Text] [Related]
12. Cellular models to investigate biochemical pathways in Parkinson's disease. Alberio T; Lopiano L; Fasano M FEBS J; 2012 Apr; 279(7):1146-55. PubMed ID: 22314200 [TBL] [Abstract][Full Text] [Related]
13. Generation and properties of a new human ventral mesencephalic neural stem cell line. Villa A; Liste I; Courtois ET; Seiz EG; Ramos M; Meyer M; Juliusson B; Kusk P; Martínez-Serrano A Exp Cell Res; 2009 Jul; 315(11):1860-74. PubMed ID: 19327351 [TBL] [Abstract][Full Text] [Related]
14. Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analyses. McCurdy RD; Féron F; Perry C; Chant DC; McLean D; Matigian N; Hayward NK; McGrath JJ; Mackay-Sim A Schizophr Res; 2006 Feb; 82(2-3):163-73. PubMed ID: 16406496 [TBL] [Abstract][Full Text] [Related]
15. Neurogenic potential of human mesenchymal stem cells revisited: analysis by immunostaining, time-lapse video and microarray. Bertani N; Malatesta P; Volpi G; Sonego P; Perris R J Cell Sci; 2005 Sep; 118(Pt 17):3925-36. PubMed ID: 16091422 [TBL] [Abstract][Full Text] [Related]
16. The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. Duda JE; Shah U; Arnold SE; Lee VM; Trojanowski JQ Exp Neurol; 1999 Dec; 160(2):515-22. PubMed ID: 10619569 [TBL] [Abstract][Full Text] [Related]
17. NRF2 activation restores disease related metabolic deficiencies in olfactory neurosphere-derived cells from patients with sporadic Parkinson's disease. Cook AL; Vitale AM; Ravishankar S; Matigian N; Sutherland GT; Shan J; Sutharsan R; Perry C; Silburn PA; Mellick GD; Whitelaw ML; Wells CA; Mackay-Sim A; Wood SA PLoS One; 2011; 6(7):e21907. PubMed ID: 21747966 [TBL] [Abstract][Full Text] [Related]
18. Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Schulz TC; Noggle SA; Palmarini GM; Weiler DA; Lyons IG; Pensa KA; Meedeniya AC; Davidson BP; Lambert NA; Condie BG Stem Cells; 2004; 22(7):1218-38. PubMed ID: 15579641 [TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of MPP+-treated MN9D cells: a mechanism of toxicity study. Wang J; Xu Z; Fang H; Duhart HM; Patterson TA; Ali SF Neurotoxicology; 2007 Sep; 28(5):979-87. PubMed ID: 17475336 [TBL] [Abstract][Full Text] [Related]
20. From stem cells to neural networks: recent advances and perspectives for neurodevelopmental disorders. Gaspard N; Vanderhaeghen P Dev Med Child Neurol; 2011 Jan; 53(1):13-7. PubMed ID: 21087236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]